Home / Cyproheptadine / Czechia
CZ ATC R06AX02 · updated 2 Nov 2026
Cyproheptadine shortage in Czechia
Is there a Cyproheptadine shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Cyproheptadine product is reported short in Czechia, the first since 31 Oct 2024. The company estimate for the return is 30 Jun 2027. Main reason: regulatory or licensing.
Not reported short in any other country we track. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | PERITOL 4MG 4MG TBL NOB 20 | Egis Pharmaceuticals PLC, Budapešť | 31 Oct 2024 | 30 Jun 2027 | Regulatory or licensing Procesní-registrační důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.